Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Kedrion has formed a research partnership with Columbia University Irving Medical Center to develop and test a new IgG therapy for COVID-19.
read more
Thursday, October 08, 2020
KemPharm has expanded its relationship with Corium through a new consultation services agreement under which KemPharm will provide product development consultation services to Corium.
read more
Kemwell Biopharma announced it has manufactured and supplied drug substance in India for clinical trials that will be performed by its customer in USA for an IND filing.
read more
Friday, December 07, 2012
Ken Phelps, one of the nation’s leading experts in the 505(b)(2) development pathway, will be a keynote speaker at the EPPIC Annual Conference in San Francisco, January 6.
read more
Kenco, a third-party logistics (3PL) provider, has partnered with QPharma, a provider of cloud-based compliance solutions, to add pharmaceutical sample fulfillment to their Life Sciences Division.
read more
Wednesday, September 10, 2025
Strides Pharma Science announced that its subsidiary, Strides Pharma Global Pte. Limited, Singapore, has entered into a strategic product development partnership with Kenox Pharmaceuticals, a contract development and manufacturing company ...
read more
Wednesday, January 29, 2025
Kenox Pharmaceuticals Inc. announced the addition of small scale non-sterile GMP capabilities to support GLP pre-clinical studies to its comprehensive suite of drug development services.
read more
Wednesday, January 16, 2019
Key Biologics and CRBS announced a multi-year agreement to provide researchers in academia, pharma and biotech with vital blood products for research and product manufacturing efforts.
read more
Key Biologics and Astarte Biologics announced the launch of an IRB-approved initiative to support the research, therapeutic, and vaccine communities with access to blood products collected from COVID-19 convalescent donors.
read more
Tuesday, September 04, 2018
Key Biologics and Blood Centers of America announced an agreement to formalize their existing business relationship and to broaden support for cell therapy and regenerative medicine.
read more
With the global market for asthma and COPD drugs set to reach $47bn in 2017, inhalation drug delivery systems are gathering momentum as pharmaceutical companies develop faster acting and more effective orally inhaled products. It is crucial for ...
read more
Veeva Systems and Kinapse Ltd., a provider of life sciences advisory and operational services, announced that Kinapse has selected Veeva Vault Submissions to power its new regulatory operational services.
read more
Kincell Bio, a CDMO focused on cell therapies, received $36 million in new funding. Kineticos Ventures led Kincell’s launch funding.
read more
Wednesday, February 11, 2026
Kincell Bio announced a new collaboration with RegCell. Under the partnership, Kincell Bio will provide comprehensive CMC development and GMP manufacturing support to accelerate RegCell’s lead Treg program toward clinical trial evaluation.
read more
Kincell Bio announced a significant strategic investment to expand and strengthen its Research Triangle Park (RTP), North Carolina facility. The expansion reinforces Kincell Bio's commitment to supporting clients as they advance from late-stage ...
read more